Zylox-Tonbridge Medical Technology Co Ltd Class H Logo
CNE100004JD2
A3CS7H
2190.HK

Zylox-Tonbridge Medical Technology Co Ltd Class H

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Zylox-Tonbridge Medical Technology Co Ltd Class H has already paid €0.028 in dividends. The last payout was in June.

Financials

In the last quarter, Zylox-Tonbridge Medical Technology Co Ltd Class H had revenue of €81.51M and net profit of €23.43M

(EUR) June 2026
YoY
Revenue 81.51M -
Gross profit 59.83M -
Net profit 23.43M -
EBITDA 25.65M -

Fundamentals

Metric Value
Market capitalization
€639.15M
Number of shares
322.06M
52-week high/low
€3.21 - €1.95
Dividend yield
1.30%
Dividends TTM
€0.028
Beta
0.31
P/E ratio
15.27
PEG ratio
0.15
P/B ratio
1.55
P/S ratio
3.87

Company profile

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices China and internationally. It primarily offers ThromBite Clot Retriever Device, which is intended to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke; Balloon Guiding Catheter; Cylone Aspiration Catheter; ZENFLEX Pro Peripheral Drug-eluting Stent System for complex lesions and restenotic symptomatic lesions; ZENFlex Peripheral Stent System to deliver a self-expanding stent to the iliac artery, superficial femoral arteries, and/or proximal popliteal arteries through a 6F delivery system; and drug-coated percutaneous transluminal angioplasty (PTA) Balloon Catheters that are indicated for PTA of stenosis or occlusion lesions in iliac, femoral, or popliteal arteries. The company also provides Ton-Bridge extra soft coils for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities, such as arteriovenous malformations and arteriovenous fistulae; microcatheter for coiling; distal access catheter; glycine micro catheter for professional physician to selectively inject or input control medium and/or embolic materials, and/or appropriate devices; Intracranial PTA balloon catheter; vascular snare; and snare retrieval kit for IVC filter. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Zhejiang, the People's Republic of China.

Name
Zylox-Tonbridge Medical Technology Co Ltd Class H
CEO
Zhong Zhao
Headquarters Hangzhou, zh
China
Website
IPO
07/05/2021
Employees 1,214

Ticker symbols

Exchange Symbol
Hkse
2190.HK
Frankfurt
818.F
Düsseldorf
818.DU
München
818.MU
🍪

Parqet  uses cookies. Learn more